Diethyl 1,4-cyclohexanedicarboxylate
Common Name: |
Diethyl 1,4-cyclohexanedicarboxylate |
IUPAC Name: |
diethyl cyclohexane-1,4-dicarboxylate |
Molecular Formula: |
C6H7NS |
SMILES: |
CCOC(=O)C1CCC(CC1)C(=O)OCC |
Inchi: |
1S/C12H20O4/c1-3-15-11(13)9-5-7-10(8-6-9)12(14)16-4-2/h9-10H,3-8H2,1-2H3 |
Inchi Key: |
KRJHRNUTLDTSKY-UHFFFAOYSA-N |
Cas No: |
72903-27-6 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
3 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
1 |
Name |
Value |
Molecular Weight (g/mol) |
125.19 |
Mass (g/mol) |
228.136 |
Molar Refractivity |
37.13 |
Net Charge |
|
HBD |
|
HBA |
1 |
Rt Bonds |
1 |
Rings |
1 |
TPSA |
51.69 |
Hetero Atoms |
4 |
Heavy Atoms |
8 |
Aromatic Heavy Atoms |
6 |
Melting Point (°C) |
|
Boiling Point (°C@760.00mm Hg) |
285.00 to 286.00 |
Vapor Pressure (mmHg@25.00 °C) |
0.003 |
Vapor Density (Air =1) |
|
Fraction Csp3 |
0.17 |
LogP |
1.919 |
iLOGP |
1.54 |
XLOGP3 |
1.03 |
WLOGP |
1.36 |
MLOGP |
0.79 |
ESOL Log S |
-1.75 |
ESOL Solubility (mg/ml) |
2.21 |
ESOL Solubility (mol/l) |
0.018 |
ESOL Class: esol_class |
Very soluble |
Ali Log S |
-1.71 |
Ali Solubility (mg/ml) |
2.47 |
Ali Solubility (mol/l) |
0.02 |
Ali Class |
Very soluble |
Silicos-IT LogSw |
-2.50 |
Silicos-IT Solubility (mg/ml) |
0.4 |
Silicos-IT Solubility (mol/l) |
0 |
Silicos-IT Class |
Soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
1 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-6.33 |
Bioavailability Score |
0.55 |
Caco2 |
1 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
0.545 |
CYP1A2 Inhibitor |
0 |
CYP2C19 Inhibitor |
0 |
CYP2C9 Inhibitor |
0 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
0.836 |
Carcinogenicity (Binary) |
0 |
Carcinogenicity (Trinary) |
Non-required |
Eye Irritation |
1 |
Hepatotoxicity |
0 |
Androgen Receptor Binding |
0 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
0 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |